UK markets open in 2 hours 31 minutes

Taro Pharmaceutical Industries Ltd. (TARO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
42.78+0.26 (+0.61%)
At close: 04:00PM EDT
42.78 +0.01 (+0.02%)
After hours: 04:02PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Total revenue
610,828
572,952
561,347
548,970
644,769
Cost of revenue
317,553
304,629
268,225
252,314
245,044
Gross profit
293,275
268,323
293,122
296,656
399,725
Operating expenses
Research development
60,364
52,243
54,540
60,152
59,777
Selling general and administrative
210,936
198,366
113,677
91,355
93,413
Total operating expenses
271,300
250,609
168,217
151,507
153,190
Operating income or loss
21,975
17,714
124,905
145,149
246,535
Interest expense
3,039
1,253
1,653
1,363
725
Total other income/expenses net
3,970
-351
-55,234
-556,396
17,856
Income before tax
74,340
38,213
77,858
-391,073
298,035
Income tax expense
28,638
12,768
19,592
9,667
53,485
Income from continuing operations
45,702
25,445
58,266
-400,740
244,550
Net income
45,702
25,445
58,266
-386,653
244,241
Net income available to common shareholders
45,702
25,445
58,266
-386,653
244,241
Basic EPS
0.87
0.68
1.55
-10.12
6.35
Diluted EPS
0.87
0.68
1.55
-10.12
6.35
Basic average shares
37,585
37,585
37,641
38,210
38,460
Diluted average shares
37,585
37,585
37,641
38,210
38,460